Epigallocatechin-3-gallate accelerates relaxation and Ca2+ transient decay and desensitizes myofilaments in healthy and Mybpc3-targeted knock-in cardiomyopathic mice

Background. Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac muscle disease with left ventricular hypertrophy, interstitial fibrosis and diastolic dysfunction. Increased myofilament Ca2+ sensitivity could be the underlying cause of diastolic dysfunction. Epigallocatechin-3-gall...

Full description

Bibliographic Details
Main Authors: Felix W. Friedrich, Frederik Flenner, Mahtab Nasib, Thomas Eschenhagen, Lucie Carrier
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-12-01
Series:Frontiers in Physiology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphys.2016.00607/full
_version_ 1817994564710957056
author Felix W. Friedrich
Felix W. Friedrich
Frederik Flenner
Frederik Flenner
Mahtab Nasib
Mahtab Nasib
Thomas Eschenhagen
Thomas Eschenhagen
Lucie Carrier
Lucie Carrier
author_facet Felix W. Friedrich
Felix W. Friedrich
Frederik Flenner
Frederik Flenner
Mahtab Nasib
Mahtab Nasib
Thomas Eschenhagen
Thomas Eschenhagen
Lucie Carrier
Lucie Carrier
author_sort Felix W. Friedrich
collection DOAJ
description Background. Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac muscle disease with left ventricular hypertrophy, interstitial fibrosis and diastolic dysfunction. Increased myofilament Ca2+ sensitivity could be the underlying cause of diastolic dysfunction. Epigallocatechin-3-gallate (EGCg), a catechin found in green tea has, been reported to decrease myofilament Ca2+ sensitivity in HCM models with troponin mutations. However, whether this is also the case for HCM-associated thick filament mutations is not known. Therefore, we evaluated whether EGCg affects the behavior of cardiomyocytes and myofilaments of a HCM mouse model carrying a gene mutation in cardiac myosin-binding protein C and exhibiting both increased myofilament Ca2+ sensitivity and diastolic dysfunction.Methods and Results. Acute effects of EGCg were tested on fractional sarcomere shortening and Ca2+ transients in intact ventricular myocytes and on force-Ca2+ relationship of skinned ventricular muscle strips isolated from Mybpc3-targeted knock-in (KI) and wild-type (WT) mice. Fractional sarcomere shortening and Ca2+ transients were analyzed at 37 °C under 1-Hz pacing in the absence or presence of EGCg (1.8 µM). At baseline and in the absence of Fura-2, KI cardiomyocytes displayed lower diastolic sarcomere length, higher fractional sarcomere shortening, longer time to peak shortening and time to 50% relengthening than WT cardiomyocytes. In WT and KI neither diastolic sarcomere length nor fractional sarcomere shortening were influenced by EGCg treatment, but relaxation time was reduced, to a greater extent in KI cells. EGCg shortened time to peak Ca2+ and Ca2+ transient decay in Fura-2-loaded WT and KI cardiomyocytes. EGCg did not influence phosphorylation of phospholamban. In skinned cardiac muscle strips, EGCg (30 µM) decreased Ca2+ sensitivity in both groups. Conclusion. EGCg fastened relaxation and Ca2+ transient decay to a larger extent in KI than in WT cardiomyocytes. This effect could be partially explained by myofilament Ca2+ desensitization.
first_indexed 2024-04-14T01:54:41Z
format Article
id doaj.art-b519bb49ef43498eb4e84a49d52c185a
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-04-14T01:54:41Z
publishDate 2016-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-b519bb49ef43498eb4e84a49d52c185a2022-12-22T02:19:09ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2016-12-01710.3389/fphys.2016.00607233197Epigallocatechin-3-gallate accelerates relaxation and Ca2+ transient decay and desensitizes myofilaments in healthy and Mybpc3-targeted knock-in cardiomyopathic miceFelix W. Friedrich0Felix W. Friedrich1Frederik Flenner2Frederik Flenner3Mahtab Nasib4Mahtab Nasib5Thomas Eschenhagen6Thomas Eschenhagen7Lucie Carrier8Lucie Carrier9University Medical Center EppendorfGerman Centre for Cardiovascular Research, partner site Hamburg/Kiel/LübeckUniversity Medical Center EppendorfGerman Centre for Cardiovascular Research, partner site Hamburg/Kiel/LübeckUniversity Medical Center EppendorfGerman Centre for Cardiovascular Research, partner site Hamburg/Kiel/LübeckUniversity Medical Center EppendorfGerman Centre for Cardiovascular Research, partner site Hamburg/Kiel/LübeckUniversity Medical Center EppendorfGerman Centre for Cardiovascular Research, partner site Hamburg/Kiel/LübeckBackground. Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac muscle disease with left ventricular hypertrophy, interstitial fibrosis and diastolic dysfunction. Increased myofilament Ca2+ sensitivity could be the underlying cause of diastolic dysfunction. Epigallocatechin-3-gallate (EGCg), a catechin found in green tea has, been reported to decrease myofilament Ca2+ sensitivity in HCM models with troponin mutations. However, whether this is also the case for HCM-associated thick filament mutations is not known. Therefore, we evaluated whether EGCg affects the behavior of cardiomyocytes and myofilaments of a HCM mouse model carrying a gene mutation in cardiac myosin-binding protein C and exhibiting both increased myofilament Ca2+ sensitivity and diastolic dysfunction.Methods and Results. Acute effects of EGCg were tested on fractional sarcomere shortening and Ca2+ transients in intact ventricular myocytes and on force-Ca2+ relationship of skinned ventricular muscle strips isolated from Mybpc3-targeted knock-in (KI) and wild-type (WT) mice. Fractional sarcomere shortening and Ca2+ transients were analyzed at 37 °C under 1-Hz pacing in the absence or presence of EGCg (1.8 µM). At baseline and in the absence of Fura-2, KI cardiomyocytes displayed lower diastolic sarcomere length, higher fractional sarcomere shortening, longer time to peak shortening and time to 50% relengthening than WT cardiomyocytes. In WT and KI neither diastolic sarcomere length nor fractional sarcomere shortening were influenced by EGCg treatment, but relaxation time was reduced, to a greater extent in KI cells. EGCg shortened time to peak Ca2+ and Ca2+ transient decay in Fura-2-loaded WT and KI cardiomyocytes. EGCg did not influence phosphorylation of phospholamban. In skinned cardiac muscle strips, EGCg (30 µM) decreased Ca2+ sensitivity in both groups. Conclusion. EGCg fastened relaxation and Ca2+ transient decay to a larger extent in KI than in WT cardiomyocytes. This effect could be partially explained by myofilament Ca2+ desensitization.http://journal.frontiersin.org/Journal/10.3389/fphys.2016.00607/fullRelaxationHypertrophic Cardiomyopathyepigallocatechin-3-gallateCa2+ transientMyofilament Ca2+ sensitivityMYBPC3
spellingShingle Felix W. Friedrich
Felix W. Friedrich
Frederik Flenner
Frederik Flenner
Mahtab Nasib
Mahtab Nasib
Thomas Eschenhagen
Thomas Eschenhagen
Lucie Carrier
Lucie Carrier
Epigallocatechin-3-gallate accelerates relaxation and Ca2+ transient decay and desensitizes myofilaments in healthy and Mybpc3-targeted knock-in cardiomyopathic mice
Frontiers in Physiology
Relaxation
Hypertrophic Cardiomyopathy
epigallocatechin-3-gallate
Ca2+ transient
Myofilament Ca2+ sensitivity
MYBPC3
title Epigallocatechin-3-gallate accelerates relaxation and Ca2+ transient decay and desensitizes myofilaments in healthy and Mybpc3-targeted knock-in cardiomyopathic mice
title_full Epigallocatechin-3-gallate accelerates relaxation and Ca2+ transient decay and desensitizes myofilaments in healthy and Mybpc3-targeted knock-in cardiomyopathic mice
title_fullStr Epigallocatechin-3-gallate accelerates relaxation and Ca2+ transient decay and desensitizes myofilaments in healthy and Mybpc3-targeted knock-in cardiomyopathic mice
title_full_unstemmed Epigallocatechin-3-gallate accelerates relaxation and Ca2+ transient decay and desensitizes myofilaments in healthy and Mybpc3-targeted knock-in cardiomyopathic mice
title_short Epigallocatechin-3-gallate accelerates relaxation and Ca2+ transient decay and desensitizes myofilaments in healthy and Mybpc3-targeted knock-in cardiomyopathic mice
title_sort epigallocatechin 3 gallate accelerates relaxation and ca2 transient decay and desensitizes myofilaments in healthy and mybpc3 targeted knock in cardiomyopathic mice
topic Relaxation
Hypertrophic Cardiomyopathy
epigallocatechin-3-gallate
Ca2+ transient
Myofilament Ca2+ sensitivity
MYBPC3
url http://journal.frontiersin.org/Journal/10.3389/fphys.2016.00607/full
work_keys_str_mv AT felixwfriedrich epigallocatechin3gallateacceleratesrelaxationandca2transientdecayanddesensitizesmyofilamentsinhealthyandmybpc3targetedknockincardiomyopathicmice
AT felixwfriedrich epigallocatechin3gallateacceleratesrelaxationandca2transientdecayanddesensitizesmyofilamentsinhealthyandmybpc3targetedknockincardiomyopathicmice
AT frederikflenner epigallocatechin3gallateacceleratesrelaxationandca2transientdecayanddesensitizesmyofilamentsinhealthyandmybpc3targetedknockincardiomyopathicmice
AT frederikflenner epigallocatechin3gallateacceleratesrelaxationandca2transientdecayanddesensitizesmyofilamentsinhealthyandmybpc3targetedknockincardiomyopathicmice
AT mahtabnasib epigallocatechin3gallateacceleratesrelaxationandca2transientdecayanddesensitizesmyofilamentsinhealthyandmybpc3targetedknockincardiomyopathicmice
AT mahtabnasib epigallocatechin3gallateacceleratesrelaxationandca2transientdecayanddesensitizesmyofilamentsinhealthyandmybpc3targetedknockincardiomyopathicmice
AT thomaseschenhagen epigallocatechin3gallateacceleratesrelaxationandca2transientdecayanddesensitizesmyofilamentsinhealthyandmybpc3targetedknockincardiomyopathicmice
AT thomaseschenhagen epigallocatechin3gallateacceleratesrelaxationandca2transientdecayanddesensitizesmyofilamentsinhealthyandmybpc3targetedknockincardiomyopathicmice
AT luciecarrier epigallocatechin3gallateacceleratesrelaxationandca2transientdecayanddesensitizesmyofilamentsinhealthyandmybpc3targetedknockincardiomyopathicmice
AT luciecarrier epigallocatechin3gallateacceleratesrelaxationandca2transientdecayanddesensitizesmyofilamentsinhealthyandmybpc3targetedknockincardiomyopathicmice